A Blow to Global Health: The End of HIV Vaccine Trials in South Africa
The Wits laboratory in Johannesburg buzzed with activity and anticipation. Researchers were on the brink of launching clinical trials of an HIV vaccine, a beacon of hope in a region burdened by the world’s highest rates of HIV. But an email changed everything, halting their work. The Trump administration’s decision to withdraw U.S. funding for global health initiatives has plunged the BRILLIANT research project into uncertainty, putting the future of HIV…